Anti-Angiogenic Activity Of Bevacizumab-Bearing Dexamethasone-Loaded PLGA Nanoparticles For Potential Intravitreal Applications

QR Code

Anti-Angiogenic Activity Of Bevacizumab-Bearing Dexamethasone-Loaded PLGA Nanoparticles For Potential Intravitreal Applications

Jiaxin Liu, Xueyan Zhang, Ge Li, Fei Xu, Shuang Li, Lesheng Teng, Youxin Li, Fengying Sun School of Life Sciences, Jilin University, Changchun, Jilin, People’s Republic of ChinaCorrespondence: Youxin Li; Fengying SunSchool of Life Sciences, Jilin University, 2699 Qianjin Street, Changchun,...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Liu J, Zhang X, Li G, Xu F, Li S, Teng L, Li Y, Sun F
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2019
Sujets:	nanoparticles dexamethasone bevacizumab anti-angiogenesis vegf Medicine (General) R5-920
Accès en ligne:	https://doaj.org/article/d479c0ab0b8f4c3d92d6e2d5d758c1b1
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Intravitreal bevacizumab injections versus dexamethasone implant for treatment-naïve retinal vein occlusion related macular edema
par: Laine I, et autres
Publié: (2017)

Timing of neovascular regression in eyes with high-risk proliferative diabetic retinopathy without macular edema treated initially with intravitreous bevacizumab
par: Shakarchi FI, et autres
Publié: (2018)

Dual-Ligand-Modified Liposomes Co-Loaded with Anti-Angiogenic and Chemotherapeutic Drugs for Inhibiting Tumor Angiogenesis and Metastasis
par: Wang F, et autres
Publié: (2021)

Managing Diabetic Macular Edema in Clinical Practice: Systematic Review and Meta-Analysis of Current Strategies and Treatment Options
par: Veritti D, et autres
Publié: (2021)

Outcome of Single Dexamethasone Implant Injection in the Treatment of Persistent Diabetic Macular Edema After Anti-VEGF Treatment: Real-Life Data from a Tertiary Hospital in Jordan
par: Al-Latayfeh M, et autres
Publié: (2021)

Effectiveness of prophylactic intravitreal bevacizumab injection to proliferative diabetic retinopathy patients with elevated preoperative intraocular VEGF in preventing complications after vitrectomy
par: Tsubota K, et autres
Publié: (2019)

Contralateral eye-to-eye comparison of intravitreal ranibizumab and a sustained-release dexamethasone intravitreal implant in recalcitrant diabetic macular edema
par: Thomas BJ, et autres
Publié: (2016)

Mesoporous silica nanoparticles as a delivery system for improving antiangiogenic therapy
par: Sun JG, et autres
Publié: (2019)

Characterization and bioactivity of self-assembled anti-angiogenic chondroitin sulphate-ES2-AF nanoparticle conjugate
par: Xing L, et autres
Publié: (2019)

Intravitreal aflibercept for choroidal neovascularization associated with chorioretinitis: a pilot study
par: Korol AR, et autres
Publié: (2017)

The First WHO International Standard for Harmonizing the Biological Activity of Bevacizumab
par: Haiyan Jia, et autres
Publié: (2021)

Anatomical and functional response after conversion to aflibercept using the treat-and-extend regimen protocol in bevacizumab treatment-resistant wet age-related macular degeneration
par: Taipale C, et autres
Publié: (2018)

Methanolic extract of Euchelus asper exhibits in-ovo anti-angiogenic and in vitro anti-proliferative activities
par: Agrawal,Sweta, et autres
Publié: (2017)

Effects of Intravitreal Bevacizumab Therapy in Patients with Proliferative Diabetic Retinopathy
par: Ribeiro de Carvalho G, et autres
Publié: (2020)

Aflibercept versus Ranibizumab as a Second Line Therapy After Bevacizumab for Diabetic Macular Edema
par: Alsaedi NG, et autres
Publié: (2021)

Safety of high-dose intravitreal triamcinolone acetonide as low-cost alternative to anti-vascular endothelial growth factor agents in lower-middle-income countries
par: Ghoraba HH, et autres
Publié: (2018)

Pilot study of the safety and efficacy of angiogenic therapy in diabetic foot syndrome
par: Igor L. Plaksa, et autres
Publié: (2019)

Short-Term Changes in Intraocular Pressure After Intravitreal Injection of Bevacizumab for the Treatment of Retinopathy of Prematurity
par: Obata S, et autres
Publié: (2019)

Long-term corticosteroid-induced chronic glaucoma model produced by intracameral injection of dexamethasone-loaded PLGA microspheres
par: MJ Rodrigo, et autres
Publié: (2021)

NLRP3 Blockade Suppresses Pro-Inflammatory and Pro-Angiogenic Cytokine Secretion in Diabetic Retinopathy
par: Chai G, et autres
Publié: (2020)

Safety of bilateral same-day intravitreal injections of anti-vascular endothelial growth factor agents
par: Ruão M, et autres
Publié: (2017)

Glaucoma drainage device implantation with adjunctive intravitreal bevacizumab in neovascular glaucoma: 3-year experience
par: Noor NA, et autres
Publié: (2017)

Intravitreal Ranibizumab or Aflibercept After Bevacizumab in Diabetic Macular Edema: Exploratory Retrospective Analysis
par: Pessoa B, et autres
Publié: (2021)

Baseline Subfoveal Choroidal Thickness as a Predictor for Response to Short-Term Intravitreal Bevacizumab Injections in Diabetic Macular Edema
par: Dweikat A, et autres
Publié: (2021)

Expresión de VEGF-A y VEGFR2 en Miocardio de Pollos Tratados con Ácido Acetilsalicílico (AAS)
par: Sepúlveda,Francisco, et autres
Publié: (2019)

ROLE OF ANGIOGENIC FACTORS FOR TRANSPLACENTAL TRANSFER OF THE MEASLES ANTIBODIES
par: A. D. Shmitko, et autres
Publié: (2019)

Retinal reperfusion in diabetic retinopathy following treatment with anti-VEGF intravitreal injections
par: Levin AM, et autres
Publié: (2017)

The outcome of low-frequency intravitreal bevacizumab therapy for macular edema in retinal vein occlusions
par: Ivanovska Adjievska B, et autres
Publié: (2017)

Gold nanoparticles and angiogenesis: molecular mechanisms and biomedical applications
par: Darweesh RS, et autres
Publié: (2019)

Growth and neurodevelopmental status in patients with retinopathy of prematurity treated with intravitreal bevacizumab: a case–control study
par: Majid Abrishami, et autres
Publié: (2021)

Antiangiogenic properties of nanoparticles: a systematic review
par: Saeed BA, et autres
Publié: (2019)

Long-term results of combination therapy using anti-VEGF agents and dexamethasone intravitreal implant for retinal vein occlusion: an investigational case series
par: Singer MA, et autres
Publié: (2016)

REC8 suppresses tumor angiogenesis by inhibition of NF-κB-mediated vascular endothelial growth factor expression in gastric cancer cells
par: Liu,Miao, et autres
Publié: (2020)

Synthetic anti-angiogenic genomic therapeutics for treatment of neovascular age-related macular degeneration
par: Jing Wang, et autres
Publié: (2021)

Activity of PD-1 Inhibitor Combined With Anti-Angiogenic Therapy in Advanced Sarcoma: A Single-Center Retrospective Analysis
par: Yang You, et autres
Publié: (2021)

Treatment of refractory uveitic macular edema: results of a first and second implant of long-acting intravitreal dexamethasone
par: Zola M, et autres
Publié: (2017)

Cetuximab-modified CuS nanoparticles integrating near-infrared-II-responsive photothermal therapy and anti-vessel treatment
par: Li B, et autres
Publié: (2018)

Evaluation Of The Timing Of Intravitreal Bevacizumab Injection As Adjuvant Therapy To Panretinal Photocoagulation In Patients With Diabetic Macular Edema Secondary To Diabetic Retinopathy
par: Kartasasmita A, et autres
Publié: (2019)

The treatment of nonunions with application of BMP-7 increases the expression pattern for angiogenic and inflammable cytokines: a matched pair analysis
par: Haubruck P, et autres
Publié: (2016)

Angiogenesis and Tumor Progression Inhibition of Cyclooxygenase-2 Selective Inhibitor Celecoxib Associated with Poly (lactic-co-glycolic acid) in Tumor Cell Line Resistant to Chemotherapy
par: Roa,Ignacio, et autres
Publié: (2017)